- 27.5k views
Anticoagulants in CVD
The financial burden of thrombotic events in cardiovascular disease is enormous. Anticoagulant medication is advised for the treatment and secondary prevention of acute coronary syndrome as well as the prevention of thrombotic events in numerous cardiovascular disorders, such as stroke in atrial fibrillation. Present-day parenteral anticoagulants consist of fondaparinux, low-molecular-weight heparins (LMWHs), and unfractionated heparin. When admitted to the hospital, patients with acute coronary syndrome are typically given either unfractionated heparin or a low-molecular weight heparin (LMWH). Both treatments are equally effective in lowering the risk of death and myocardial infarction, although LMWHs may be safer and don't need to be monitored for blood clotting. Using fondaparinux reduces mortality from acute coronary syndrome considerably when compared to LMWHs or unfractionated heparin. However, long-term outpatient usage of parenteral medications is inconvenient. The only oral anticoagulants available at this time are vitamin K antagonists. A large unmet need exists for new convenient and well-tolerated oral anticoagulants that do not require routine monitoring.
About the Speaker
Dr. Abhishek Tiwari
Consultant Interventional Cardiologist, Ahalia Hospital, Coimbatore
Dr. Abhishek Tiwari, Consultant Interventional Cardiologist, Ahalia Hospital, Coimbatore
Upcoming Case Discussions
Acne: Disorders and Treatment Approaches
Acne is a common dermatological condition caused by clogged pores, excess sebum production, bacterial growth, and inflammation. It can manifest as blackheads, whiteheads, papules, pustules, or cysts, often leading to scarring if untreated. Various factors, including hormonal changes, diet, stress, and genetics, influence its severity. Treatment approaches range from topical and oral medications, such as retinoids, antibiotics, and hormonal therapy, to advanced procedures like chemical peels and laser therapy. A personalized skincare regimen, along with lifestyle modifications, plays a crucial role in managing and preventing acne.
Congenital Uterine Anomalies
Congenital uterine anomalies are structural abnormalities of the uterus resulting from improper fusion, canalization, or resorption of the Müllerian ducts during fetal development. These anomalies include septate, bicornuate, unicornuate, and didelphys uterus, among others. They can be asymptomatic or associated with infertility, recurrent pregnancy loss, preterm birth, or abnormal menstruation. Diagnosis is typically made using imaging modalities like ultrasound, MRI, or hysterosalpingography. Treatment depends on the type and severity of the anomaly, with surgical correction such as hysteroscopic septum resection often indicated in symptomatic cases. Early detection is crucial for optimizing reproductive outcomes and guiding appropriate management strategies.
Management of Postoperative Pain: Best Practices for GP’s
Effective management of postoperative pain is crucial for promoting recovery and preventing complications. General practitioners should start by assessing pain severity using appropriate scales, then tailor the treatment plan based on the patient's medical history and the type of surgery. A combination of pharmacological approaches, such as non-opioid analgesics (e.g., NSAIDs) and opioids when necessary, should be used to minimize pain while reducing the risk of addiction. Multimodal strategies, including physical therapy and non-pharmacological techniques like cold therapy or mindfulness, can further enhance pain relief. Close follow-up is essential to adjust the treatment as needed and ensure the patient's pain is well-controlled.
Diabetes and Stem Cells: What Does the Future Hold?
The future of diabetes treatment may be revolutionized by stem cell research, offering hope for a long-term cure. Scientists are developing stem cell therapies that could regenerate insulin-producing beta cells in the pancreas, potentially restoring natural insulin production in people with type 1 diabetes. Early clinical trials have shown promising results, with some patients reducing or eliminating their need for insulin injections. While challenges like immune rejection and long-term efficacy remain, continued advancements suggest stem cell therapy could significantly change diabetes management in the coming years.
Author Post
Impact
+
Talks
+
webinar
+
no.of registrations
One liner about speaker
Why is speaker relevant?
Dr. Abhishek Tiwari's Talks on Assimilate
- 12th -Sep-2024, TIME : 5:00PM TO 6:00 PM
- 0
The financial burden of thrombotic events in cardiovascular disease is enormous. Anticoagulant medication is advised for the treatment and secondary prevention of acute coronary syndrome as well as the prevention of thrombotic events in numerous cardiovascular disorders, such as stroke in atrial fibrillation. Present-day parenteral anticoagulants consist of fondaparinux, low-molecular-weight heparins (LMWHs), and unfractionated heparin. When admitted to the hospital, patients with acute coronary syndrome are typically given either unfractionated heparin or a low-molecular weight heparin (LMWH). Both treatments are equally effective in lowering the risk of death and myocardial infarction, although LMWHs may be safer and don't need to be monitored for blood clotting. Using fondaparinux reduces mortality from acute coronary syndrome considerably when compared to LMWHs or unfractionated heparin. However, long-term outpatient usage of parenteral medications is inconvenient. The only oral anticoagulants available at this time are vitamin K antagonists. A large unmet need exists for new convenient and well-tolerated oral anticoagulants that do not require routine monitoring.